PREVALENCE OF OSTEOPOROSIS IN THE TURKISH WOMEN, RISK FACTORS AND THEIR AWARENESS ABOUT OSTEOPOROSIS ACCORDING TO THE CAMPAIGN OF "HEALTHY BONES & STRONG WOMEN"

Basit Öğe Kaydı
dc.contributor.authorKirazli, Y. K.
dc.contributor.authorCalis, F. C. A. Atamaz
dc.contributor.authorTuzun, S. T.
dc.contributor.authorEl, O. E.
dc.contributor.authorPeker, O. P.
dc.contributor.authorDurmaz, B. D.
dc.contributor.authorOncel, S. O.
dc.date.accessioned2019-10-27T10:06:55Z
dc.date.available2019-10-27T10:06:55Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.descriptionWCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases -- APR 19-22, 2018 -- Krakow, POLANDen_US
dc.description.sponsorshipWCO, Int Osteoporosis Fdn, European Soc Clin & Econ Aspects Osteoporosis, Osteoarthritis & Musculoskeletal Dis, Sinklar Conf Management B V, Mylan, Lilly, UCB, Medimaps, OsteoSys, Echolight, Abiogen Pharma, Bioventus, Pierre Fabre, Amgen, IBSA, Medi, Kyowa Kirin, Wisepress Com, EffRx, Alexion, Hologic, GE, Galgo Med, Bindex, AgNovos, Theramex, Fidia Pharma Grp, Biomedica, Radius, Roche, Sequolaen_US
dc.identifier.endpageS494en_US
dc.identifier.issn0937-941X
dc.identifier.issn1433-2965
dc.identifier.startpageS493en_US
dc.identifier.urihttps://hdl.handle.net/11454/30502
dc.identifier.volume29en_US
dc.identifier.wosWOS:000440102404088en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofOsteoporosis Internationalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePREVALENCE OF OSTEOPOROSIS IN THE TURKISH WOMEN, RISK FACTORS AND THEIR AWARENESS ABOUT OSTEOPOROSIS ACCORDING TO THE CAMPAIGN OF "HEALTHY BONES & STRONG WOMEN"en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu